Table 1 Baseline demographics
Healthy controls | Alzheimer’s disease | p-value | |
|---|---|---|---|
Number of participants | 15 | 25 | |
Age, mean (SD) | 69.5 (7.93) | 70.3 (7.79) | 0.723 |
Males/females | 8/7 | 15/10 | 0.680 |
Education, mean (SD) | 15.2 (2.04) | 14.3 (3.08) | 0.219 |
Cholinesterase inhibitor, n (%) | 0 | 24 (96%) | |
SSRI/SNRI, n (%) | 1 (7%) | 4 (16%) | |
MMSE, mean (SD) | 29.3 (0.88) | 23.4 (3.29) | < 0.001 |
NPI | 4.83 (4.06) | ||
FAQ IADL | 14.28 (5.78) | ||
Time in days between MRI and ear-EEG, mean (SD)* | 21.4 (12.46) | 17.8 (10.26) | 0.332 |
Left hippocampus volume, % of ICV, mean (SD) | 0.26 (0.03) | 0.21 (0.03) | < 0.001 |
Right hippocampus volume, % of ICV, mean (SD) | 0.26 (0.3) | 0.21 (0.03) | < 0.001 |